Feb 3, 2020   SOURCE: PR NewsWire

Polycystic Ovarian Syndrome Treatment Market to Reach $4.18 Bn, Globally, by 2026 at 4.7% CAGR: Allied Market Research

PORTLAND, Oregon, Feb. 3, 2020 /PRNewswire/ -- Allied Market Research published a report, titled, "Polycystic Ovarian Syndrome Treatment Market by Drug Class (Insulin Sensitizing Agent, Oral Contraceptive, Antiandrogens, Anti-Obesity Drugs, and Others), and Distribution Channel (Hospital Pharmacy, Drug Store & Retail Pharmacy, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2019-2026." According to the report, the global polycystic ovarian syndrome treatment industry was estimated at $2.90 billion in 2018 and is expected to hit $4.18 billion by 2026, registering a CAGR of 4.7% from 2019 to 2026.

https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Drivers, restraints and opportunities-

Rise in incidence of PCOS, surge in number of pipeline drugs, and increase in healthcare expenditure worldwide fuel the growth of the global polycystic ovarian syndrome treatment market. On the other hand, lack of approved therapeutics for treatment of PCOS curtails down the growth to some extent. However, higher number of unmet needs for treatment of PCOS are expected to create a number of opportunities for the key players in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6314

The insulin segment to retain its dominance by 2026-

Based on drug class, the insulin segment accounted for more than one-third of the global polycystic ovarian syndrome treatment market share in 2018, and is expected to rule the roost by the end of 2026. Easy accessibility of the drugs, technological advancements for detection of PCOS, and preferable usage of insulin sensitizing agents in management of PCOS are majorly driving segment growth. The oral segment, on the other hand, would cite the fastest CAGR of 5.7% from 2019 to 2026. Key advantages offered by oral contraceptives such as regulation of female hormone, reduction of hair loss & acne, and cost effectivity boost the growth of the segment.

The drug segment to maintain the lion's share during the estimated period-

Based on distribution channel, the drug segment held the major share in 2018, generating nearly three-fifths of the global polycystic ovarian syndrome treatment market. The segment is expected to maintain its dominant position throughout the forecast period. At the same time, the online segment would grow at the fastest CAGR of 6.3% during the study period. These pharmacies offer various advantages such as more convenience, fewer expenses, easy access to patient reviews, and price comparisons, which fuel the growth of the segment.

North America to lead the trail till 2026-

Based on geography, North America contributed to nearly half of the global polycystic ovarian syndrome treatment market revenue in 2018, and is projected to dominate till 2026. Higher prevalence of PCOS, rise in healthcare awareness, presence of well-developed healthcare infrastructure along with early detection of the disease, increase in the number of trained medical professionals, and easy accessibility to the therapeutics are the major factors driving the market growth in the region. Simultaneously, the region across Asia-Pacific would register the fastest CAGR of 6.3% throughout the forecast period. Surge in health awareness, development in healthcare infrastructure, rise in number of hospitals & diagnostic centers equipped with advanced medical facilities, and increase in number of target population in the emerging economies are the prime factors that instigate the market growth.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6314

Key market players-

    --  AstraZeneca plc.
    --  Pfizer Inc.
    --  SANOFI
    --  Teva Pharmaceutical Industries
    --  Bayer AG
    --  Novartis AG
    --  Bristol-Myers Squibb Company
    --  Allergan plc.
    --  Johnson and Johnson
    --  Mylan N.V.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

Similar Reports:

Psoriatic Arthritis Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019-2026

Alopecia Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019-2026

Antifibrinolytic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019-2026

TAVI: Global Opportunity Analysis and Industry Forecast, 2019-2026

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

View original content:http://www.prnewswire.com/news-releases/polycystic-ovarian-syndrome-treatment-market-to-reach-4-18-bn-globally-by-2026-at-4-7-cagr-allied-market-research-300997540.html

SOURCE Allied Market Research